Skip to content

Pharmaceutical Science

ISSN 3033-3318

6 papers in the library · publishing 2025

Papers

Sort Most recent Most cited

Psychedelics in Psychiatry: New Treatment Paradigms or Addictive Treatment Strategies? A Narrative Review

Pharmaceutical Science December 9, 2025 Marco Otto Toscano, Serena Chiara Civardi, Federico Durbano

Scientific interest in psychedelics, documented since the nineteenth century, has recently resurged after decades of prohibition. Contemporary research highlights their therapeutic potential in treatment-resistant psychiatric disorders, alongside their heuristic value for studying brain networks and consciousness. This chapter reviews the historical trajectory, traditional uses, mechanisms of...

DOI: 10.5772/intechopen.1014070 (opens in new tab) Enthusiasm Narrative review Perspective graphical Ambivalence +7

Psychedelics for the Treatment of Substance Use Disorder

Pharmaceutical Science October 13, 2025 Berta Fumàs, David Pubill, Raúl López‐arnau et al.

Substance Use Disorder (SUD) is a chronic, relapsing mental health condition characterized by compulsive substance use despite harmful consequences. According to the World Health Organization, in 2021, approximately 39.5 million individuals worldwide suffered from drug use disorders, contributing to an estimated 600,000 deaths annually. Moreover, current pharmacological treatment, such as...

Psychedelics that Heal and Harm – Their Therapeutic and Recreational Use

Pharmaceutical Science September 4, 2025 Faheema Aziz Wani, Irfan Ahmad Wani

Psychedelic drugs, known for their profound effects on perception, cognition, and emotion, have long captivated scientific, cultural, and therapeutic interest. Following the discovery of LSD’s psychoactive properties in 1943, research surged into its therapeutic potential and the nature of consciousness. However, the integration of psychedelics into the 1960s counterculture led to moral panic,...

Therapeutic Potential of Psychedelics: Mechanisms, Applications, and Challenges

Pharmaceutical Science August 27, 2025 Guilllermo Castaño-perez, Sara Isabel Castaño-ocampo

The resurgence of research on the use of psychedelic substances for the treatment of mental disorders and addictions has generated significant interest in the scientific and clinical communities. This chapter examines the current evidence on the efficacy, safety, and limitations of psychedelics in the treatment of these conditions. Studies investigating the use of psychedelics as monotherapy...

Psychedelics’ Intoxicating Impact and Behavioural Dynamics

Pharmaceutical Science August 19, 2025 Afshan Zeeshan Wasti

Psychedelics such as psilocybin and lysergic acid diethylamide upset the brain networks involved in self-awareness and emotion and may lead to altered perception, cognition, and social behaviour, although unsupervised use is still dangerous due to their unpredictable psychological and physiological effects. These drugs cause emotions to be amplified, the ego to dissolve, and sensory vividness...

Ayahuasca-Induced Serotonin Syndrome: Risks, Mechanisms, and Clinical Considerations

Pharmaceutical Science August 1, 2025 Melissa Ortega

Ayahuasca is a traditional Amazonian brew composed primarily of Banisteriopsis caapi and Psychotria viridis, drawing increasing interest for its psychedelic effects and potential therapeutic applications. Its pharmacological action is based on the synergistic combination of β-carbolines (harmine, tetrahydroharmine, and harmaline), which act as reversible inhibitors of monoamine oxidase A...